Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey

 

Moffitt Cancer Center
Avatar

Real-World Use of Pemigatinib for Cholangiocarcinoma Among Racial and Ethnic Minorities in The United States

By Moffitt Cancer Center FEATURING Richard Kim
By Moffitt Cancer Center FEATURING Richard Kim
55 views
February 27, 2024
0 Comments
Login to view comments. Click here to Login
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
13:45
Flavio Rocha

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

06:22
Milind Javle

Importance of Molecular Profiling in Biliary Tract Cancer

30:00
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Managing Treatment-Related Side Effects in GI Cancers: Chemo, Target…

Feat. P. Griffith
03:51
Moffitt Cancer Center

Real-World Characteristics, Treatment Patterns, and Outcomes of Pati…

Feat. R. Kim
04:16
Moffitt Cancer Center

Real-World Use of Pemigatinib for Cholangiocarcinoma Among Racial an…

Feat. R. Kim
08:24
ASH 2022 Conference Coverage

Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…

Feat. A. Vannucchi
16:57
Scripps MD Anderson Cancer Center

What’s New: Oncology Drug Updates - Part 2

Feat. B. Do
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda